Modifiable lifestyle factors and ovarian cancer incidence in women
More details
Hide details
Department of Mother’s and Child’s Health, University of Medical Sciences, Poznań, Poland
Department for Woman Health, Institute of Rural Health in Lublin, Poland
Corresponding author
Katarzyna Plagens-Rotman   

Department of Mother’s and Child’s Health, University of Medical Sciences, Poznań, Poland
Ann Agric Environ Med. 2018;25(1):36-40
A correct diet plays an important role in the prevention of malignant tumours. The risk of the disease may be reduced by introducing a number of changes to the daily diet. The most important changes concern the amount of fat in the diet, dietary fibre, antioxidants in the food and the reduction of substances having a significant impact on the development of malignant tumours.

The aim of the study is to analyse the role of selected modifiable lifestyle factors affecting the development of ovarian cancer.

Material and Methods:
The study covered healthy women and women with diagnosed ovarian cancer. A total of 850 women aged between 21–84 were studied. The study included women visiting the Gynaecology and Obstetrics Hospital of the University of Medical Sciences in Poznan, Poland, between 2011–2013. Patients recognized with malignant ovarian cancer were qualified into the study based on the histopathological examination of the material obtained during surgery.

Respondents who consumed fruit and vegetables several times a week have the odds ratio OR = 0.29 level; 95% CI 0.04–2.01 (p =.2085), compared to women not consuming fruit and vegetables at all. Consumption of 100 g of French fries and potato chips several times a week, results in a 2-fold increase in ovarian cancer. The OR for this group of women amounts to 2.06; 95% CI 0.53–7.99 (p=.2966).

A diet rich in fruit and vegetables, including bulb vegetables, and grain products containing whole grains, should be introduced. It is recommended that the consumption of popular fast foods be eliminated.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893–2917. doi: 10.1002/ijc.25516.
Słabuszewska-Jóźwiak A, Dmoch-Gajzlerska E, Kozakiewicz B, Jakiel G. The prognostic significance of thrombocytosis in ovarian cancer. Ann Agric Environ Med. 2015; 4: 731–735.
Domżał-Drzewicka R, Charzyńska-Gula M, Włoszczak-Szubzda A. A voice in the discussion concerning causes for late diagnostics of cancer of the reproductive organ in women, based on the example of the Lublin Region. Ann Agric Environ Med. 2014; 2: 221–223.
Gromadzka A, Kubiczak M, Jankowska A. Gene therapy applications in gynecologic malinances management. Ginekol Pol. 2010; 81(1): 50–54.
Szychta P, Szychta W, Lewiński A, Karbownik-Lewińska M. Co-existence of chronic non-communicable diseases and common neoplasms among 2,462 endocrine adult inpatients – a retrospective analysis. Ann Agric Environ Med. 2015; 4: 747–754. doi: 10.5604/12321966.1185785.
Andreyeva T, Michaud P-C, van Soest A. Obesity and health in Europeans aged 50 years and older. Public Health, 2007; 121: 497–509.
Olsen CM, Nagle CM, Whiteman DC, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer 2013, 22; 20(2): 251–262. doi: 10.1530/ERC-12-0395.
Pan SY, Johnson KC, Ugnat AM. Association of Obesity and Cancer Risk in Canada. Am J Epidemiol 2004;159: 259–268.
Zatońska K, Campos H, Ilow R, et al. Dietary intake and adipose tissue level of specific fatty acids in a selected group from the Lower Silesia population. Ann Agric Environ Med. 2012; 19(3): 389–394.
Abel S, Riedel S, Gelderblom WC. Dietary PUFA and cancer. Proc Nutr Soc. 2014; 73(3): 361–367. doi: 10.1017/S0029665114000585.
Schwab U, Lauritzen L, Tholstrup T. Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review. Food Nutr Res. 2014; 10: 58. doi: 10.3402/fnr.v58.25145.
Wan XH, Fu X, Ababaikeli G. Docosahexaenoic Acid Induces Growth Suppression on Epithelial Ovarian Cancer Cells More Effectively than Eicosapentaenoic Acid. Nutr Cancer 2016; 68: 320–327. doi: 10.1080/01635581.2016.1142581.
Abel S, Riedel S, Gelderblom WC. Dietary PUFA and cancer. Proc Nutr Soc. 2014; 73: 361–367. doi: 10.1017/S0029665114000585.
Kolahdooz F, van der Pols JC, Bain CJ, et al. Meat, fish, and ovarian cancer risk: Results from 2 Australian case – control studies, a systematic review, and meta – analysis. Am J Clin Nutr. 2010; 91: 1752–1763. doi: 10.3945/ajcn.2009.28415.
Jiang PY, Jiang ZB, Shen KX, Yue Y. Fish intake and ovarian cancer risk: a meta-analysis of 15 case-control and cohort studies. PLoS One. 2014 Apr 14; 9(4): e94601. doi: 10.1371/journal.pone.0094601.
Merritt MA, Poole EM, Hankinson SE, Willett WC, Tworoger SS. Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer. Cancer Causes Control 2014; 25: 795–808. doi: 10.1007/s10552-014-0381-7.
Larsson SC, Giovannucci E, Wolk A. Folate and Risk of Breast Cancer: A Metaanalysis. J Natl Cancer Inst. 2007; 99: 64–76.
Plagens-Rotman K, Żak E, Pięta B. Odds ratio analysis in women with endometrial cancer. Menopause Rev. 2016; 1: 12–19. doi: 10.5114/pm.2016.58767.
Tang L, Lee AX, Su D, Binns CW. Fruit and vegetable consumption associated with reduced risk of epithelial ovarian cancer in southern Chinese women. Gynecol Oncol. 2014; 132: 241–247. doi: 10.1016/j.ygyno.2013.10.020.
Schulz M, Lahmann PH, Boeing H, Hoffmann K, Allen N, Key TJ, et al. Fruit and vegetable consumption and risk of epithelial ovarian cancer: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2005;14: 2531–2535.
Keck A, Finley JW. Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and selenium. Integrative Cancer Therapies 2004; 3: 5–12.
Han B, Li X, Yu T. Cruciferous vegetables consumption and the risk of ovarian cancer: a meta-analysis of observational studies. Diagn Pathol. 2014; 20(9) :7. doi: 10.1186/1746-1596-9-7.
Bosetti C, Filomeno M, Riso P, et al. Cruciferous vegetables and cancer risk in a network of case-control studies. Ann Oncol. 2012; 23(8): 2198–2203. doi: 10.1093/annonc/mdr604.
Khanum F, Anilakumar KR, Viswanathan KR. Anticarcinogenic properties of garlic: a review. Crit Rev Food Sci Nutr. 2004; 44: 479–488.
Dębski B, Milner JA. Molekularne mechanizmy przeciwnowotworowego działania czosnku; Rola reaktywnych form tlenu. [Molecular mechanisms of anticancer properties of garlic; The role of free radicals]. BROMAT. CHEM. TOKSYKOL. – XL, 2007; 3: 223–228.
Powolny AA, Singh SV. Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetablederived organosulfur compounds. Cancer Lett. 2008; 2692: 305–314. doi: 10.1016/j.canlet.2008.05.027.
Journals System - logo
Scroll to top